Renato Martins Selected Research

ErbB Receptors (EGF Receptor)

5/2023	Family Matters: Germline Testing in Thoracic Cancers.
7/2005	Erlotinib in previously treated non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renato Martins Research Topics

Disease

12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2023 - 07/2005
10	Neoplasms (Cancer) 05/2023 - 06/2010
4	Squamous Cell Carcinoma of Head and Neck 01/2020 - 01/2016
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2021 - 01/2016
2	Lung Neoplasms (Lung Cancer) 05/2023 - 01/2019
2	Carcinogenesis 05/2023 - 01/2019
2	Salivary Gland Neoplasms (Salivary Gland Cancer) 12/2021 - 01/2020
1	Mesothelioma 05/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2022
1	Chronic Disease (Chronic Diseases) 01/2018
1	Genomic Instability 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2015
1	Disease Progression 09/2011
1	Pulmonary Atelectasis 02/2011
1	Proteinuria 06/2010
1	Chronic Renal Insufficiency 06/2010
1	Hepatitis 06/2010
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 06/2010
1	Hypertension (High Blood Pressure) 06/2010

Drug/Important Bio-Agent (IBA)

3	Immune Checkpoint InhibitorsIBA 10/2022 - 01/2019
3	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 09/2009
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2014 - 07/2005
2	ErbB Receptors (EGF Receptor)IBA 05/2023 - 07/2005
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 12/2014
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 09/2011
2	Cetuximab (Erbitux)FDA Link 01/2017 - 01/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 09/2011
2	Monoclonal AntibodiesIBA 09/2015 - 06/2010
1	AsbestosIBA 05/2023
1	CarcinogensIBA 05/2023
1	Etoposide (VP 16)FDA LinkGeneric 10/2022
1	PlatinumIBA 10/2022
1	130-nm albumin-bound paclitaxelIBA 01/2021
1	atezolizumabIBA 01/2020
1	pembrolizumabIBA 01/2020
1	Vorinostat FDA Link 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	adavosertibIBA 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	Gefitinib (Iressa)FDA Link 12/2014
1	dacomitinibIBA 12/2014
1	Formaldehyde (Formol)FDA Link 01/2014
1	ParaffinIBA 01/2014
1	NucleotidesIBA 01/2014
1	Ataxia Telangiectasia Mutated ProteinsIBA 06/2012
1	LigandsIBA 06/2012
1	Carboplatin (JM8)FDA LinkGeneric 09/2011
1	CreatinineIBA 09/2011
1	Bevacizumab (Avastin)FDA Link 06/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2010
1	Gemcitabine FDA Link 09/2009
1	Pemetrexed (MTA)FDA Link 09/2009

Therapy/Procedure

11	Therapeutics 01/2021 - 09/2011
6	Drug Therapy (Chemotherapy) 10/2022 - 07/2005
3	Radiotherapy 12/2021 - 12/2014
2	Immunotherapy 01/2020 - 01/2017
1	Image-Guided Radiotherapy 01/2020
1	Aftercare (After-Treatment) 01/2018
1	Intermittent Positive-Pressure Breathing 02/2011